Rosiglitazone Tartrate Dispersible Tablets

  • Favorite
Newlystar (Ningbo) Medtech Co., Ltd.

Business Type:Trader

Country/Region:China

Ddu Verified

HOT Rank

8/10

Product Information

  • Dosage Form:Tablet
  • Route of Administration:Oral
  • Shelf Life:3 years
  • Storage:Sealed

Description

Product : Rosiglitazone Tartrate Dispersible Tablets 

Specification : 4mg

Standard : In - house

Packing : 6’s/blister


Description :

Rosiglitazone Tartrate is an oral antidiabetic agent which acts primarily by increasing insulin sensitivity. Rosiglitazone Tartrate improves glycemic control while reducing circulating insulin levels.

Rosiglitazone Tartrate is not chemically or functionally related to the sulfonylureas, the biguanides, or the alpha-glucosidase inhibitors.

Each pentagonal film-coated tablet contains rosiglitazone Tartrate equivalent to rosiglitazone 4 mg for oral administration.


Indications and Usage :

1 Monotherapy and Combination Therapy

Rosiglitazone Tartrate Dispersible Tablets is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.


2 Important Limitations of Use

Due to its mechanism of action, Rosiglitazone Tartrate Dispersible Tablets is active only in the presence of endogenous insulin. Therefore, Rosiglitazone Tartrate Dispersible Tablets should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis.

The coadministration of Rosiglitazone Tartrate Dispersible Tablets and insulin is not recommended.

The use of Rosiglitazone Tartrate Dispersible Tablets with nitrates is not recommended.


You Might Also Like
Change a group
Inquiry Cart(0)